Sage Investment Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$236K Hold
266
0.25% 65
2024
Q2
$241K Sell
266
-129
-33% -$103K 0.27% 59
2024
Q1
$307K Sell
395
-211
-35% -$150K 0.35% 54
2023
Q4
$353K Sell
606
-13
-2% -$7.59K 0.43% 47
2023
Q3
$333K Buy
619
+17
+3% +$8.76K 0.46% 45
2023
Q2
$282K Sell
602
-80
-12% -$33.5K 0.38% 47
2023
Q1
$234K Buy
+682
New +$230K 0.31% 52

Other funds holding LLY

Sage Investment Advisers's LLY Position: Q3 2024 in Review

Sage Investment Advisers held its Eli Lilly (LLY) position steady in Q3 2024 at 266 shares worth $236K. The position accounts for 0.25% of the portfolio, ranked #65.

Sage Investment Advisers first reported a position in LLY in Q1 2023 and has held it in 7 quarters since. The position peaked at $353K in Q4 2023. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Sage Investment Advisers held 266 shares of Eli Lilly worth $236K as of Q3 2024.
  • Sage Investment Advisers left its Eli Lilly share count unchanged in Q3 2024.
  • Eli Lilly made up 0.25% of Sage Investment Advisers's portfolio in Q3 2024, its #65 holding.
  • Sage Investment Advisers first reported a position in Eli Lilly in Q1 2023 and has held it in 7 quarters since.
  • Sage Investment Advisers's Eli Lilly position peaked at $353K in Q4 2023.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Sage Investment Advisers's 13F filing for Q3 2024, filed 4 Nov 2024.